Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAE4fjpFDsOgx8wo9dbZiwgSvtxFxCBLp0amYP0AbeGoQ#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _3 provenance.
- assertion hadPrimarySource 17909047 provenance.
- _3 wasQuotedFrom 17909047 provenance.
- _3 value "About 35 mRNAs were dysregulated in the erlotinib-treated group, whereas no significant change in the mRNAs from the celecoxib alone?treated group was found. Analysis of these results revealed that a large subset of genes involved in cell cycle progression or cellular proliferation was differentially regulated. The effect of celecoxib and erlotinib on mRNA levels of these genes are summarized in Table 1 . (HCA-7 cells, a human colorectal cancer cell line, were injected s.c. into the flank region of athymic nu/nu mice.) " provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.